메뉴 건너뛰기
Journal of Neurology
Volumn 259, Issue 1, 2012, Pages 168-169
Concerns about studies investigating new anticoagulant drugs for stroke prevention in atrial fibrillation
Author keywords

[No Author keywords available]
Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; APIXABAN; CREATININE; DABIGATRAN; RIVAROXABAN; WARFARIN;
EID: 84856741622     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6328-y     Document Type: Letter
Times cited : (2)
References (8)
  • 1
    • 80052825103 scopus 로고    scopus 로고
    • Apixaban versus warfarin in patients with atrial fibrillation
    • 21870978 10.1056/NEJMoa1107039 1:CAS:528:DC%2BC3MXhtF2ms7rN
    • CB Granger JH Alexander JJ McMurray, et al. 2011 Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 365 981 992 21870978 10.1056/NEJMoa1107039 1:CAS:528:DC%2BC3MXhtF2ms7rN
    • (2011) N Engl J Med , vol.365 , pp. 981-992
    • Granger, C.B.1    Alexander, J.H.2    McMurray, J.J.3
  • 2
    • 70349306707 scopus 로고    scopus 로고
    • Dabigatran versus warfarin in patients with atrial fibrillation
    • 19717844 10.1056/NEJMoa0905561 1:CAS:528:DC%2BD1MXhtFOjsLnN
    • SJ Connolly MD Ezekowitz S Yusuf, et al. 2009 Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 1139 1151 19717844 10.1056/NEJMoa0905561 1:CAS:528:DC%2BD1MXhtFOjsLnN
    • (2009) N Engl J Med , vol.361 , pp. 1139-1151
    • Connolly, S.J.1    Ezekowitz, M.D.2    Yusuf, S.3
  • 3
    • 80052592404 scopus 로고    scopus 로고
    • Rivaroxaban versus warfarin in nonvalvular atrial fibrillation
    • 21830957 10.1056/NEJMoa1009638 1:CAS:528:DC%2BC3MXhtFKhsLnI
    • MR Patel KW Mahaffey J Garg, et al. 2011 Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 883 891 21830957 10.1056/NEJMoa1009638 1:CAS:528:DC%2BC3MXhtFKhsLnI
    • (2011) N Engl J Med , vol.365 , pp. 883-891
    • Patel, M.R.1    Mahaffey, K.W.2    Garg, J.3
  • 4
    • 79952445042 scopus 로고    scopus 로고
    • 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran)
    • 21324629 10.1016/j.jacc.2011.01.010
    • SL Wann AB Curtis KA Ellenbogen, et al. 2011 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on dabigatran) J Am Coll Cardiol 57 1330 1337 21324629 10.1016/j.jacc.2011.01.010
    • (2011) J Am Coll Cardiol , vol.57 , pp. 1330-1337
    • Wann, S.L.1    Curtis, A.B.2    Ellenbogen, K.A.3
  • 5
    • 79960586319 scopus 로고    scopus 로고
    • Dabigatran in patients with nonvalvular atrial fibrillation
    • 21777759 10.1016/j.jacc.2011.04.016
    • L Gage 2011 Dabigatran in patients with nonvalvular atrial fibrillation J Am Coll Cardiol 58 551 21777759 10.1016/j.jacc.2011.04.016
    • (2011) J Am Coll Cardiol , vol.58 , pp. 551
    • Gage, L.1
  • 6
    • 79960955075 scopus 로고    scopus 로고
    • The use of dabigatran in elderly patients
    • 21788545 10.1001/archinternmed.2011.314
    • M Legrand J Mateo A Arbaud, et al. 2011 The use of dabigatran in elderly patients Arch Intern Med 171 1285 1288 21788545 10.1001/archinternmed.2011.314
    • (2011) Arch Intern Med , vol.171 , pp. 1285-1288
    • Legrand, M.1    Mateo, J.2    Arbaud, A.3
  • 7
    • 77956492689 scopus 로고    scopus 로고
    • The frequency of prescription of P-glycoprotein-affecting drugs in atrial fibrillation
    • 20553377 10.1111/j.1538-7836.2010.03943.x 1:STN:280: DC%2BC3cbisFOltw%3D%3D
    • L Jungbauer C Dobias C Stöllberger F Weidinger 2010 The frequency of prescription of P-glycoprotein-affecting drugs in atrial fibrillation J Thromb Haemost 8 2069 2070 20553377 10.1111/j.1538-7836.2010.03943.x 1:STN:280:DC%2BC3cbisFOltw%3D%3D
    • (2010) J Thromb Haemost , vol.8 , pp. 2069-2070
    • Jungbauer, L.1    Dobias, C.2    Stöllberger, C.3    Weidinger, F.4
  • 8
    • 80052951090 scopus 로고    scopus 로고
    • Dabigatran led to less major bleeding than warfarin in younger but not older patients with atrial fibrillation
    • ACP Journal Club
    • ACP Journal Club 2011 Dabigatran led to less major bleeding than warfarin in younger but not older patients with atrial fibrillation Ann Intern Med 155 JC3-3
    • (2011) Ann Intern Med , vol.155 , pp. 3-3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.